| Literature DB >> 34142595 |
Hsiu-An Wu1, Chien-Hung Chen1, Ming-Hsien Hsieh1, Yung-Chang Wu1, Jung-Peng Chiu1, Chien-Jung Huang1, Chung-Hua Hsu1,2.
Abstract
OBJECTIVE: Cancer patients undergo therapies that might lead to severe adverse events. The enhanced daycare of Traditional Chinese medicine (TCM) we describe was intended to help cancer patients suffering from severe adverse events to obtain relief. We used the Taiwan brief version of the Common Terminology Criteria for Adverse Events Version 4.0 (Taiwan brief version questionnaire of CTCAE) as a primary measurement to evaluate the efficacy of the enhanced day care of TCM. The secondary measurements were the Taiwanese version of the Brief Fatigue Inventory (BFI-T) questionnaire and the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire, which were used to quantify fatigue and quality of life (QOL), respectively. METHODS/Entities:
Keywords: TCM; adverse events; complementary medicine; enhanced daycare
Year: 2021 PMID: 34142595 PMCID: PMC8216359 DOI: 10.1177/15347354211025634
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Figure 1.The flow chart of the study.
Characteristics of the Participants.
| Demographics | n (%) | Mean ± SD |
|---|---|---|
| Sex | ||
| Male | 112(27.9) | |
| Female | 289(72.1) | |
| Age | 59.13 ± 9.24 | |
| Height (cm) | 159.98 ± 7.53 | |
| Weight (kg) | 58.82 ± 11.13 | |
| Cancer stage | ||
| Stage I | 23(5.7) | |
| Stage II | 68(17.0) | |
| Stage III | 143(35.7) | |
| Stage IV | 167(41.6) | |
| Medical utilization | ||
| Clinic attendance per patient (visits) | 12.01 ± 9.95 | |
| Duration of treatment period(days) | 23.54 ± 18.65 | |
Abbreviations: Kg, kilogram; cm, centimeter.
Distribution of Cancer Types.
| Group | Intestinal cancer | Lung cancer | Breast cancer | Other type of cancer |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | |
| Female | 34 (8.48) | 47 (11.72) | 134 (33.42) | 75 (18.70) |
| Male | 30 (7.48) | 23 (5.74) | 0 (0.00) | 58 (14.46) |
| Total number | 64 (15.96) | 70 (17.46) | 134 (33.42) | 133 (33.17) |
Note. The denominator is the total number of medical records (n = 401).
Differences on the CTCAE.
| Group | Pretest (n = 401) | Posttest (n = 401) | |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Total score of CTCAE | 13.05 ± 4.78 | 11.38 ± 4.70 | <.001 |
| Fatigue | 1.56 ± 0.59 | 1.35 ± 0.57 | <.001 |
| Anemia | 0.49 ± 0.73 | 0.47 ± 0.71 | .48 |
| Febrile neutropenia | 0.07 ± 0.37 | 0.04 ± 0.24 | .08 |
| Pain | 1.28 ± 0.78 | 1.17 ± 0.72 | .003 |
| Diarrhea | 0.39 ± 0.74 | 0.24 ± 0.53 | <.001 |
| Constipation | 0.29 ± 0.58 | 0.25 ± 0.53 | .06 |
| Vomiting | 0.17 ± 0.52 | 0.08 ± 0.33 | <.001 |
| Anorexia | 0.92 ± 0.89 | 0.73 ± 0.84 | <.001 |
| Oral mucositis | 0.35 ± 0.66 | 0.29 ± 0.55 | .04 |
| Salivary duct inflammation | 0.41 ± 0.65 | 0.33 ± 0.54 | .003 |
| Dysphagia | 0.36 ± 0.64 | 0.29 ± 0.58 | .004 |
| Dyspnea | 0.54 ± 0.75 | 0.48 ± 0.72 | .03 |
| Cystitis noninfective | 0.10 ± 0.35 | 0.08 ± 0.34 | .29 |
| Abdominal distension | 0.83 ± 0.70 | 0.76 ± 0.67 | .04 |
| Dry mouth | 0.79 ± 0.60 | 0.73 ± 0.58 | .03 |
| Anxiety | 0.94 ± 0.71 | 0.81 ± 0.69 | <.001 |
| Depression | 0.82 ± 0.68 | 0.75 ± 0.68 | .01 |
| Insomnia | 1.27 ± 0.85 | 1.12 ± 0.82 | <.001 |
| Cough | 0.39 ± 0.61 | 0.38 ± 0.59 | .85 |
| Rash | 0.30 ± 0.60 | 0.30 ± 0.60 | 1 |
| Palmar plantar erythrodysesthesia syndrome | 0.23 ± 0.50 | 0.24 ± 0.49 | .77 |
| Peripheral sensory neuropathy | 0.54 ± 0.71 | 0.47 ± 0.67 | .02 |
Note. *P < .05 with statistical significance.
P < .005 with statistical significance.
Differences on BFI-T and WHOQOL-BREF.
| Group | Pretest (n = 401) | Posttest (n = 401) | |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| BFI-T | 49.91 ± 18.18 | 45.66 ± 18.64 | <.001 |
| BREF-A | 2.69 ± 0.80 | 2.79 ± 0.77 | .001 |
| BREF-B | 2.22 ± 0.72 | 2.35 ± 0.73 | <.001 |
| BREF-P | 18.84 ± 2.84 | 18.99 ± 3.04 | .22 |
| BRED-M | 16.68 ± 2.88 | 16.80 ± 2.72 | .24 |
| BREF-S | 12.58 ± 2.14 | 12.60 ± 2.19 | .73 |
| BREF-E | 28.49 ± 4.45 | 29.70 ± 4.44 | .17 |
Note. A: self-evaluation quality of life; B: self-evaluation total health condition.
Abbreviations: P, physical aspect; M, mental aspect; S, social aspect; E, environmental aspect.
P < .05 with statistical significance.
P < .005 with statistical significance.
Differences on Different Cancer Stages Comparisons.
| Group | Cancer stage I | Cancer stage II | Cancer stage III | Cancer stage IV | |
|---|---|---|---|---|---|
| n = 23, 5.74% | n = 68, 16.96% | n = 143, 35.66% | n = 167, 41.65% | ||
| Mean (SD), | Mean (SD), | Mean (SD), | Mean (SD), | ||
| CTCAE | −1.96 (2.85), .003 | −1.90 (6.08), .01 | −1.24 (3.84), <.001 | −1.90 (3.80), <.001 | .52 |
| BFI-T | −0.65 (12.44), .80 | −4.06 (13.69), .02 | −4.31 (15.4), .001 | −4.77 (14.28), <.001 | .65 |
| BREF-A | 0.09 (0.60), .49 | 0.06 (0.77), .53 | 0.13 (0.59), .01 | 0.10 (0.58), .04 | .91 |
| BREF-B | 0.22 (0.60), .10 | 0.25 (0.63), .002 | 0.10 (0.55), .03 | 0.10 (0.69), .07 | .28 |
| BREF-P | 0.00 (1.68), 1 | −0.13 (1.96), .58 | 0.32 (2.27), .10 | 0.14 (2.68), .51 | .63 |
| BREF-M | 0.04 (2.01), .92 | 0.43 (1.83), .06 | 0.13 (2.03), .43 | 0.01 (2.31), .97 | .59 |
| BREF-S | 0.30 (0.97), .15 | 0.00 (1.11), 1 | 0.08 (1.18), .40 | −0.05 (1.80), .70 | .66 |
| BREF-E | 0.39 (2.59), .48 | 0.12 (2.52), .70 | 0.28 (2.10), .11 | 0.16 (3.93), .60 | .97 |
Note. P, PAIR-T.
P < .05 with statistical significance.
P < .005 with statistical significance.